STOCK TITAN

News for XCRT Stock

Xcelerate, Inc. Announces Funding Xcelerate, Inc. Announces the Launch of the Ceramedx Tik Tok Skincare Campaign Xcelerate, Inc. Issues Shareholder Update Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications Xcelerate, Inc. Releases Shareholder Update Xcelerate, Inc. Retains Investment Bank Craft Capital Management to Provide Investment Banking and Up-Listing Advisory Services Xcelerate, Inc. Addresses Concerns About Recently Released Research Report Xcelerate, Inc. Announces Change of Auditors Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report Xcelerate, Inc. Announces That ESN Group, Inc. Has Gone Live on the Army & Air Force Exchange Service Online Exchange Xcelerate, Inc. Engages Leading Investor Relations Firm Darrow Associates to Enhance Capital Markets Presence Xcelerate, Inc. Announces Participation in The Microcap Conference Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor to Army & Air Force Exchange Service Xcelerate Announces Marketing Agreement Xcelerate, Inc. Acquires a Majority Interest in ESN Group Xcelerate, Inc. Announces Interview With CEO Michael O'Shea Xcelerate, Inc. Announces PTO and PCT Filings For Surgical Devices Xcelerate, Inc. Announces Agreement to Acquire a Controlling Interest in ESN, Inc. Xcelerate Announces that Afya Sasa Signs Agreement with the National Hospital of Tanzania Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc. Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc Xcelerate, Inc. Releases Message from CEO Xcelerate, Inc. to Develop Consumer Healthcare Products Additional Countries Add Patent Protection Xcelerate, Inc. Announces Uplisting to OTCQB Market Xcelerate, Inc. Applies to Trade on the OTCQB Venture Marketplace Cathy Scangarella to Join the Advisory Board of Xcelerate, Inc. Wilken, O’Shea Talk Acquisition of HS Pharmaceuticals and What It Means for The Future Of XCRT Xcelerate, Inc. Announces Appointment of New Board Member Xcelerate, Inc. Expands IP with Acquisition of Patent Portfolio Xcelerate, Inc. (OTC Markets: XCRT) Retains SmallCapVoice.com Inc. to Provide Investor Relations Services SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Markets: XCRT) and Dr. Dilan Ellegala Xcelerate Advisory Board Member Discussing the Launch of a Pilot Program in Tanzania Xcelerate, Inc. Files Medical Surgical Device Patent Thomas E. Mannle, Jr. to Join the Advisory Board of Xcelerate, Inc. Xcelerate, Inc. Launches Pilot Project in Four African Hospitals Xcelerate, Inc. CEO Discusses Using AI to Advance Medical Care in Africa in Interview with SmallCapVoice.com Michael O’Shea CEO, Releases Shareholder Update Fran White to Join the Advisory Board of Xcelerate, Inc. Xcelerate Files Supplemental Information For Removal of Shell Status Xcelerate, Inc. Issues Shareholder Update Xcelerate Acquires Controlling Interest in AfiyaSasa Africa Xcelerate, Inc. Signs Definitive Memorandum of Understanding with HS Pharmaceuticals, LLC Xcelerate Completes Audit of Consolidated Annual Financial Statements Xcelerate, Inc. Retains Accounting Firm For Audit Xcelerate, Inc. Announces Investment Banking Agreements for Consulting Services and Acquisition Financing Dr. Barry Marshall Shares Xcelerate's Mission In Advancing Medical Technology On ticker NEWS' Globally-Streamed Broadcast Xcelerate, Inc. Signs Letter of Intent to Explore Business Relationship with HS Pharmaceuticals Xcelerate Inc. Announces Removal of "Yield" Sign on OTC Markets Stock Quotes Xcelerate, Inc. Unveils Website That Crosses the Divide Between Non-Medical Engineering and Clinical Care Head of Non-Standard Investments at FinTrust, Vincent C. du Vigneaud, Joins Advisory Board of Xcelerate, Inc. Xcelerate, Inc. Now Trading Under Ticker Symbol XCRT
Back to Sitemap